Search Results - "Conroy, Melissa J"

Refine Results
  1. 1

    Real-time ex vivo monitoring of NK cell migration toward obesity-associated oesophageal adenocarcinoma following modulation of CX3CR1 by Mylod, Eimear, O’Connell, Fiona, Donlon, Noel E., Davern, Maria, Marion, Caroline, Butler, Christine, Reynolds, John V., Lysaght, Joanne, Conroy, Melissa J.

    Published in Scientific reports (18-02-2024)
    “…Oesophagogastric adenocarcinomas (OAC) are poor prognosis, obesity-associated cancers which may benefit from natural killer (NK) cell-based immunotherapies…”
    Get full text
    Journal Article
  2. 2

    Harnessing Natural Killer Cells in Non-Small Cell Lung Cancer by Russell, Éilis, Conroy, Melissa J, Barr, Martin P

    Published in Cells (Basel, Switzerland) (10-02-2022)
    “…Lung cancer is the leading cause of cancer-related deaths worldwide. There are two main subtypes: small cell lung cancer (SCLC), and non-small cell lung cancer…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Identifying a Novel Role for Fractalkine (CX3CL1) in Memory CD8 + T Cell Accumulation in the Omentum of Obesity-Associated Cancer Patients by Conroy, Melissa J, Maher, Stephen G, Melo, Ashanty M, Doyle, Suzanne L, Foley, Emma, Reynolds, John V, Long, Aideen, Lysaght, Joanne

    Published in Frontiers in immunology (13-08-2018)
    “…The omentum is enriched with pro-inflammatory effector memory CD8 T cells in patients with the obesity-associated malignancy, esophagogastric adenocarcinoma…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Investigating the Effects of Olaparib on the Susceptibility of Glioblastoma Multiforme Tumour Cells to Natural Killer Cell-Mediated Responses by Moran, Jennifer, Mylod, Eimear, Kane, Laura E, Marion, Caroline, Keenan, Emily, Mekhaeil, Marianna, Lysaght, Joanne, Dev, Kumlesh K, O'Sullivan, Jacintha, Conroy, Melissa J

    Published in Pharmaceutics (20-01-2023)
    “…Glioblastoma multiforme (GBM) is the most common adult primary brain malignancy, with dismal survival rates of ~14.6 months. The current standard-of-care…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Natural killer cell therapy: A new frontier for obesity-associated cancer by Mylod, Eimear, Lysaght, Joanne, Conroy, Melissa J.

    Published in Cancer letters (01-06-2022)
    “…Natural killer (NK) cell infiltration of solid tumours is associated with better outcomes, placing augmentation of NK cell abundance in tumours as an…”
    Get full text
    Journal Article
  10. 10
  11. 11

    The multifactorial effect of obesity on the effectiveness and outcomes of cancer therapies by Lysaght, Joanne, Conroy, Melissa J.

    Published in Nature reviews. Endocrinology (23-09-2024)
    “…Epidemiology studies have demonstrated a clear association between obesity and the development of several distinct malignancies, with excessive visceral…”
    Get full text
    Journal Article
  12. 12

    Examination and characterisation of the effect of amitriptyline therapy for chronic neuropathic pain on neuropeptide and proteomic constituents of human cerebrospinal fluid by Royds, Jonathan, Cassidy, Hilary, Conroy, Melissa J., Dunne, Margaret R., Lysaght, Joanne, McCrory, Connail

    Published in Brain, behavior, & immunity. Health (01-01-2021)
    “…Amitriptyline is prescribed to reduce the intensity of chronic neuropathic pain. There is a paucity of validated in vivo evidence in humans regarding…”
    Get full text
    Journal Article
  13. 13

    Measuring Immune Cell Movement Toward the Soluble Microenvironment of Human Tissues Using a Boyden Chamber-Based Migration Assay by Mylod, Eimear, Lysaght, Joanne, Conroy, Melissa J

    “…Migration assays are used to measure cell movement toward a variety of chemoattractants in a controlled environment. Here we describe a method for a Boyden…”
    Get more information
    Journal Article
  14. 14

    CX3CL1 Signaling in the Tumor Microenvironment by Conroy, Melissa J, Lysaght, Joanne

    “…CX3CL1 (Fractalkine) is a multifunctional inflammatory chemokine with a single receptor CX3CR1. The biological effects elicited by CX3CL1 on surrounding cells…”
    Get more information
    Journal Article
  15. 15
  16. 16
  17. 17

    Chemokine-targeted therapies: An opportunity to remodel immune profiles in gastro-oesophageal tumours by O’Donovan, Cillian, Davern, Maria, Donlon, Noel E., Lysaght, Joanne, Conroy, Melissa J.

    Published in Cancer letters (28-11-2021)
    “…Immunotherapies are transforming outcomes for many cancer patients and are quickly becoming the fourth pillar of cancer therapy. However, their efficacy of…”
    Get full text
    Journal Article
  18. 18

    An investigation into the modulation of T cell phenotypes by amitriptyline and nortriptyline by Royds, Jonathan, Conroy, Melissa J., Dunne, Margaret R., McCrory, Connail, Lysaght, Joanne

    Published in European neuropsychopharmacology (01-02-2020)
    “…Amitriptyline is prescribed for treating the symptoms of neuroinflammatory disorders including neuropathic pain and fibromyalgia. As amitriptyline has evidence…”
    Get full text
    Journal Article
  19. 19

    Fractalkine Elicits Chemotactic, Phenotypic, and Functional Effects on CX3CR1+CD27− NK Cells in Obesity-Associated Cancer by Mylod, Eimear, Melo, Ashanty M., Donlon, Noel E., Davern, Maria, Bhardwaj, Anshul, Reynolds, John V., Lysaght, Joanne, Conroy, Melissa J.

    Published in The Journal of immunology (1950) (15-08-2021)
    “…Esophagogastric adenocarcinomas (EAC) are obesity-associated malignancies underpinned by severe immune dysregulation and inflammation. Our previous work…”
    Get full text
    Journal Article
  20. 20

    A study of the immune infiltrate and patient outcomes in esophageal cancer by Conroy, Melissa J, Kennedy, Susan A, Doyle, Suzanne L, Hayes, Brian, Kavanagh, Maria, van der Stok, Eric P, O'Sullivan, Katie, Cathcart, Mary-Clare, Reynolds, John V, Lysaght, Joanne

    Published in Carcinogenesis (New York) (17-04-2021)
    “…Cancer patient outcomes and selection for novel therapies are heavily influenced by the immune contexture of the tumor microenvironment. Esophageal cancer is…”
    Get full text
    Journal Article